|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2600118672 |
|
最近更新日期: Date of Last Refreshed on: |
2026-02-10 08:18:39 |
|
注册时间: Date of Registration: |
2026-02-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
“美加净抗敏护龈牙膏” 抑制牙菌斑和减轻牙龈炎症作用临床研究 |
|
Public title: |
Clinical Study on the Effects of "Meijiajing Anti-Sensitivity Gum Care Toothpaste" in Inhibiting Dental Plaque and Reducing Gum Inflammation |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
“美加净抗敏护龈牙膏” 抑制牙菌斑和减轻牙龈炎症作用临床研究 |
|
Scientific title: |
Clinical Study on the Effects of “Meijiajing Anti-Sensitivity Gum Care Toothpaste” in Inhibiting Dental Plaque and Reducing Gum Inflammation |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
钱程辉 |
研究负责人: |
钱程辉 |
|
Applicant: |
Qian Chenghui |
Study leader: |
Qian Chenghui |
|
申请注册联系人电话: Applicant telephone: |
+86 21 64730116 |
研究负责人电话:
Study leader's |
+86 21 54668040 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
qianchenghui1980@163.com |
研究负责人电子邮件: Study leader's E-mail: |
qianchenghui1980@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
上海市黄浦区北京东路356号 |
研究负责人通讯地址: |
上海市黄浦区北京东路356号 |
|
Applicant address: |
No. 356, Beijing East Road, Huangpu District, Shanghai |
Study leader's address: |
No. 356, Beijing East Road, Huangpu District, Shanghai |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
上海市口腔医院 |
||
|
Applicant's institution: |
Shanghai Stomatological Hospital |
||
|
研究负责人所在单位: |
上海市口腔医院 |
||
|
Affiliation of the Leader: |
Shanghai Stomatological Hospital |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
沪口院伦审[2025]057号 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
上海市口腔医院医学伦理委员会 |
||
|
Name of the ethic committee: |
The Ethics Committee of Shanghai Stomatological Hospital, Fudan University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2026-01-14 00:00:00 | ||
|
伦理委员会联系人: |
黄蔚 |
||
|
Contact Name of the ethic committee: |
Huang Yu |
||
|
伦理委员会联系地址: |
上海市黄浦区北京东路356号 |
||
|
Contact Address of the ethic committee: |
No. 356, Beijing East Road, Huangpu District, Shanghai |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 21 63502165 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
huangwei523@126.com |
|
研究实施负责(组长)单位: |
上海市口腔医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shanghai Stomatological Hospital |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
上海市黄浦区北京东路356号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 356, Beijing East Road, Huangpu District, Shanghai |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
上海美加净日化有限公司 |
||||||||||||||||||||||
|
Source(s) of funding: |
Shanghai Meijiajing Daily Chemical Co., Ltd. |
||||||||||||||||||||||
|
研究疾病: |
慢性牙龈炎 |
||||||||||||||||||||||
|
Target disease: |
Chronic gingivitis |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
随机平行对照 |
||||||||||||||||||||||
|
Study design: |
Parallel |
||||||||||||||||||||||
|
研究目的: |
依据原“中华人民共和国卫生部”于2010年发布的卫生行业标准WS/T 326.3-2010《牙膏功效评价 第3部分 抑制牙菌斑和(或)减轻牙龈炎症》,对上海美加净日化有限公司已上市牙膏产品“美加净抗敏护龈牙膏”的抑制牙菌斑以及减轻牙龈炎症的功效作用进行临床研究。 |
||||||||||||||||||||||
|
Objectives of Study: |
Based on the original “Ministry of Health of the People's Republic of China” health industry standard WS/T 326.3-2010 “Evaluation of Toothpaste Efficacy Part 3: Inhibition of Dental Plaque and/or Reduction of Gingival Inflammation,” clinical research was conducted on the efficacy of Shanghai Meijiajing Daily Chemical Co., Ltd.'s marketed toothpaste product “Meijiajing Sensitive Gum Care Toothpaste” in inhibiting dental plaque and reducing gingival inflammation. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
1.全身健康状况良好、无重要的全身系统性疾病、有20颗以上可检测的牙齿。 2.年龄在18周岁~70周岁。 3.具有牙龈炎(BOP%>=50%,GI2~3)。 4.没有同时参加其他类似试验研究。 |
||||||||||||||||||||||
|
Inclusion criteria |
1.In good overall health with no significant systemic diseases and at least 20 detectable teeth. 2.Ages 18 to 70. 3.Presence of gingivitis (BOP% >= 50%, GI 2–3). 4.No other similar trials or studies were conducted concurrently. |
||||||||||||||||||||||
|
排除标准: |
1.对试验牙膏成分有过敏史。 2.现在服用的药物(如:抗生素、甲硝唑等)可能对试验结果有影响的,或习惯使用漱口水者。 3.3个月内使用过其他抑菌或抗炎类牙膏。 4.口腔内有开放性龋齿或黏膜病变。 5.患严重的牙周炎。 6.有吸烟、咀嚼槟榔等影响口腔健康的不良习惯。 7.患有糖尿病、高血压等可能影响牙周健康的疾病。 8.有智力或其他缺陷而不能自主进行刷牙等口腔卫生维护者。 9.处于妊娠期和哺乳期内的女性。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1.History of allergy to ingredients in the test toothpaste. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-01-01 00:00:00至 To 2026-12-31 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-02-10 00:00:00 至 To 2026-09-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
由不参与试验的人员使用按随机数字表进行 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
By personnel who were not involved in the experiment, using the method based on the random number table |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
双盲,对研究参与者和研究者设盲 |
|
Blinding: |
Double-blind, with both the research participants and the researchers being blinded. |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF;EDC |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF;EDC |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |